Preclinical R&D Services Across Research Phases
Ace Therapeutics provides integrated preclinical contract research services across key stages of drug discovery and development. Our multidisciplinary scientific team supports research programs with specialized experimental platforms, established models, and fit-for-purpose study designs.
We provide research services that support foundational studies and early-stage therapeutic research, including gene editing, vector construction, molecular and cellular assays, and omics analysis. Study approaches can be tailored to the scientific objectives and requirements of each research program.
Our drug discovery services support the evaluation and advancement of therapeutic targets and candidates. Key capabilities include target discovery and validation, compound screening, in vitro and in vivo pharmacology, and assay development.
We provide comprehensive preclinical research services to evaluate the pharmacological activity, efficacy, pharmacokinetics, biomarkers, and safety profiles of therapeutic candidates before clinical development. Our capabilities include in vitro studies, in vivo disease models, pharmacokinetic studies, and other preclinical assessments designed to generate relevant data for development decisions.
Ace Therapeutics provides tailored preclinical research solutions aligned with the scientific objectives and development requirements of each program. Through integrated study design, experimental execution, and data analysis, we support clients in generating robust preclinical data to inform drug development decisions.
Ace Therapeutics boasts a team of highly committed and skilled researchers dedicated to delivering innovative preclinical contract research solutions.
We provide tailored preclinical services designed to streamline your research process and advance promising concepts into actionable insights, ensuring efficient progress in drug development.
Copyright © Ace Therapeutics. All rights reserved.
↑